Research Article

Phenotype-specific medication-related changes in nonlinear Poincaré descriptors of postural sway in Parkinson’s disease

Volume: 7 October 25, 2026
EN TR

Phenotype-specific medication-related changes in nonlinear Poincaré descriptors of postural sway in Parkinson’s disease

Abstract

Postural instability is a major source of disability and fall risk in Parkinson’s disease (PD), yet the effect of dopaminergic medication on balance remains inconsistent. One possible explanation is clinical heterogeneity, particularly between tremor-dominant (TD) and postural-instability/gait-difficulty (PIGD) phenotypes. In this study, nonlinear Poincaré descriptors were calculated from postural sway data to examine whether they changed with medication state differently in these two phenotypes. In a public dataset of 32 individuals with idiopathic PD, 31 participants were classified as PIGD (n=12) or TD (n=19). Quiet-standing center-of-pressure (CoP) signals were examined in OFF and ON medication states under four stance conditions combining rigid or unstable surface with eyes open or closed. Pre-filtered CoP signals were downsampled to 25 Hz and analyzed separately in the anteroposterior and mediolateral directions using lag-1 Poincaré plots to obtain SD1, SD2, and SD1/SD2, which were also compared with conventional, entropy-based, and fractal measures. Medication-related changes tended to be larger and more often positive in the PIGD group, whereas TD patients showed little systematic change. The clearest between-phenotype differences (nominal p<.05) were observed for mediolateral SD1 on an unstable surface with eyes closed, mediolateral SD2 on a rigid surface with eyes closed, and the anteroposterior SD1/SD2 ratio on an unstable surface with eyes closed; given the number of comparisons and the modest sample, these findings should be regarded as exploratory. These findings suggest that motor phenotype should be considered when interpreting medication effects on posturography in PD, and that the SD1/SD2 ratio, which closely tracked entropy- and fractal-based measures, offers a simple, parameter-free index of medication-related changes in the temporal structure of sway.

Keywords

Ethical Statement

This study is a secondary analysis of a publicly available, anonymized dataset (de Oliveira et al., 2022). The original data collection was approved by the local ethics committee, and all participants provided written informed consent; therefore, no additional ethics committee approval was required for the present analysis.

References

  1. Amisola, L. R. V., Acosta, R. J. B., Arao-Arao, H. M. D., Benitez, V. N. C., Chan, R. M. T., Co, A. K. G., ... & Virata, M. C. A. (2025). Gait analysis for Parkinson’s disease using multiscale entropy. Neurodegenerative Disease Management, 15(5), 245-258. https://doi.org/10.1080/17582024.2025.2510842
  2. Beuter, A., Hernández, R., Rigal, R., Modolo, J., & Blanchet, P. J. (2008). Postural sway and effect of levodopa in early Parkinson’s disease. Canadian Journal of Neurological Sciences, 35(1), 65-68. https://doi.org/10.1017/S0317167100007575
  3. Błaszczyk, J. W., Orawiec, R., Duda-Kłodowska, D., & Opala, G. (2007). Assessment of postural instability in patients with Parkinson’s disease. Experimental Brain Research, 183(1), 107-114. https://doi.org/10.1007/s00221-007-1024-y
  4. Crétual, A. (2015). Which biomechanical models are currently used in standing posture analysis? Neurophysiologie Clinique/Clinical Neurophysiology, 45(4-5), 285-295. https://doi.org/10.1016/j.neucli.2015.07.004
  5. Cupertino, L., Bersotti, F. M., Novaes, T. M., Mochizuki, L., Shokur, S., Bouri, M., ... & Coelho, D. B. (2025). Effect of medication and freezing of gait on rambling and trembling in quiet standing in individuals with Parkinson’s disease. Motor Control, 29(2), 202-214.
  6. de Oliveira, C. E. N., Ribeiro de Souza, C., Treza, R. C., Hondo, S. M., Los Angeles, E., Bernardo, C., ... & Coelho, D. B. (2022). A public data set with ground reaction forces of human balance in individuals with Parkinson’s disease. Frontiers in Neuroscience, 16, 865882. https://doi.org/10.3389/fnins.2022.865882
  7. De Pasquale, P., Bonanno, M., De Marchis, C., Pergolizzi, L., Lombardo Facciale, A., Paladina, G., ... & Calabrò, R. S. (2025). Beyond clinical scales: An observational study on instrumental gait analysis and biomechanical patterns in patients with Parkinson’s disease. Frontiers in Bioengineering and Biotechnology, 13, 1541240. https://doi.org/10.3389/fbioe.2025.1541240
  8. Feller, K. J., Peterka, R. J., & Horak, F. B. (2019). Sensory re-weighting for postural control in Parkinson’s disease. Frontiers in Human Neuroscience, 13, 126. https://doi.org/10.3389/fnhum.2019.00126

Details

Primary Language

English

Subjects

Biomedical Engineering (Other)

Journal Section

Research Article

Publication Date

October 25, 2026

Submission Date

April 11, 2026

Acceptance Date

October 3, 2026

Published in Issue

Year 2026 Volume: 7

APA
Tunç Çamlıbel, B. (2026). Phenotype-specific medication-related changes in nonlinear Poincaré descriptors of postural sway in Parkinson’s disease. Frontiers in Life Sciences and Related Technologies, 7, 155-166. https://doi.org/10.51753/flsrt.1927308
AMA
1.Tunç Çamlıbel B. Phenotype-specific medication-related changes in nonlinear Poincaré descriptors of postural sway in Parkinson’s disease. Front Life Sci RT. 2026;7:155-166. doi:10.51753/flsrt.1927308
Chicago
Tunç Çamlıbel, Burcu. 2026. “Phenotype-Specific Medication-Related Changes in Nonlinear Poincaré Descriptors of Postural Sway in Parkinson’s Disease”. Frontiers in Life Sciences and Related Technologies 7 (October): 155-66. https://doi.org/10.51753/flsrt.1927308.
EndNote
Tunç Çamlıbel B (October 25, 2026) Phenotype-specific medication-related changes in nonlinear Poincaré descriptors of postural sway in Parkinson’s disease. Frontiers in Life Sciences and Related Technologies 7 155–166.
IEEE
[1]B. Tunç Çamlıbel, “Phenotype-specific medication-related changes in nonlinear Poincaré descriptors of postural sway in Parkinson’s disease”, Front Life Sci RT, vol. 7, pp. 155–166, Oct. 2026, doi: 10.51753/flsrt.1927308.
ISNAD
Tunç Çamlıbel, Burcu. “Phenotype-Specific Medication-Related Changes in Nonlinear Poincaré Descriptors of Postural Sway in Parkinson’s Disease”. Frontiers in Life Sciences and Related Technologies 7 (October 25, 2026): 155-166. https://doi.org/10.51753/flsrt.1927308.
JAMA
1.Tunç Çamlıbel B. Phenotype-specific medication-related changes in nonlinear Poincaré descriptors of postural sway in Parkinson’s disease. Front Life Sci RT. 2026;7:155–166.
MLA
Tunç Çamlıbel, Burcu. “Phenotype-Specific Medication-Related Changes in Nonlinear Poincaré Descriptors of Postural Sway in Parkinson’s Disease”. Frontiers in Life Sciences and Related Technologies, vol. 7, Oct. 2026, pp. 155-66, doi:10.51753/flsrt.1927308.
Vancouver
1.Burcu Tunç Çamlıbel. Phenotype-specific medication-related changes in nonlinear Poincaré descriptors of postural sway in Parkinson’s disease. Front Life Sci RT. 2026 Oct. 25;7:155-66. doi:10.51753/flsrt.1927308

Creative Commons License

Frontiers in Life Sciences and Related Technologies is licensed under a Creative Commons Attribution 4.0 International License.